Noctrix Health Closes $40M Series C Round to Commercialize Wearable for RLS
The funding will help advance the Nidra Tonic Motor Activation therapy for restless legs syndrome toward its anticipated launch in the US.
The funding will help advance the Nidra Tonic Motor Activation therapy for restless legs syndrome toward its anticipated launch in the US.
Some seek alternatives to dopaminergic drugs, due to the drugs’ links to RLS augmentation....